Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

254027.pdf (1.61 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2022-11-12

Llicència de publicació

cc-by-nc-nd (c) Elsevier B.V., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214806

Synthesis and biological properties of palladium(II) cyclometallated compounds derived from ( E )-2-((4-hydroxybenzylidene)amino)phenol

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.jorganchem.2022.122555

Resum

( E )-2-((4-hydroxybenzylidene)amino)phenol (iminophenol a ) reacted with Pd(OAc) 2 giving place to com- pound 1a , in which the iminophenol was bonded to palladium(II) in a κ3 - C ortho ,N,O ortho tridentate chelat- ing mode. Thus, 1a was formed by neutral mononuclear units of schematic formula Pd(C,N,O), consisting of two fused five-membered metallacycles. Self-assembly of the Pd(C,N,O) units gave place to the polynu- clear structure of 1a . Treatment of 1a with PPh 3 or PPh 2 CH 2 CH 2 PPh 2 in molar ratio Pd(II)/PPh 3 = 1/1 or Pd(II)/PPh 2 CH 2 CH 2 PPh 2 = 2/1 produced the mononuclear or dinuclear compound of schematic formula [Pd(C,N,O)(PPh 3 )] ( 2a ) or {[P d (C,N,O)] 2 ( μ2 -PPh 2 CH 2 CH 2 PPh 2 )} ( 3a ), respectively. Compounds a were char- acterized by elemental analysis, high resolution ESI-( + ) mass spectrometry, IR, and NMR. In addition, the crystal structure of the adducts 2a ·2(CH 2 Cl-CH 2 Cl) and 3a ·5(dmso) was determined by single crystal X- ray diffraction analysis. Most compounds a were noncytotoxic or poorly cytotoxic. Nonetheless, 2a was moderately cytotoxic against the MCF-7 breast and HCT-116 colon human cancer cell lines, and presented very low cytotoxicity towards normal skin human BJ cells. Compounds a showed moderate antibacterial activity against some Gram-positive ( B. subtilis and S. aureus ) and Gram-negative ( E. coli ) bacterial strains, and displayed also moderate antioxidant activity, producing 3a the best antioxidant activity. 1a changed the electrophoretic mobility of the pBluescript SK + plasmid DNA. This change followed the pattern of cisplatin , but it started at a concentration twenty times higher than with cisplatin . Moreover, compounds 1a - 3a inhibited topoisomerase IIα at concentrations of 10, 50 and 25 μM, respectively.

Matèries

Pal·ladi (Element químic), Antioxidants, ADN

Matèries (anglès)

Palladium, Antioxidants, DNA

Citació

Col·leccions

Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Citació

ALBERT MACH, Joan, et al. Synthesis and biological properties of palladium(II) cyclometallated compounds derived from ( E )-2-((4-hydroxybenzylidene)amino)phenol. Journal of Organometallic Chemistry. 2022. Vol. 983, num. 1-11. ISSN 0022-328X. [consulted: 6 of August of 2026]. Available at: https://hdl.handle.net/2445/214806

Exportar metadades

JSON - METS

Compartir registre